![]() ![]() Ali-Jackson currently serves on the board of directors, audit committee, compensation committee, and is the chair of the nominating and corporate governance committee of PDS Biotechnology Corporation, a publicly traded clinical stage biopharmaceutical company, as an independent director of Moda Operandi, a privately held online luxury retail company, and as an advisor to life sciences companies and nonprofit organizations. Reddy’s Laboratories Ltd., and Endo Pharmaceuticals, Inc. She has served as legal counsel and as a licensing business executive for a number of pharmaceutical companies, including Merck & Co. a biopharmaceutical assets management company and was legal counsel for the company and its affiliated companies until 2020. ![]() Ali-Jackson also co-founded NeXeption, Inc. Ali-Jackson co-founded and successfully transitioned several specialty pharmaceutical and biopharmaceutical companies through multi-million-dollar acquisitions by global pharmaceutical companies. Ali-Jackson built the legal, compliance, and human resources functions at Aclaris. Ali- Jackson is a co-founder of Aclaris Therapeutics, Inc., a publicly traded clinical stage biopharmaceutical company, and served as its chief legal officer, chief compliance officer, and corporate secretary since its inception in 2012 until her retirement in January 2022. Covis' products make an important difference in the lives of patients, and I am excited by the opportunity to continue to expand the company's impact on patient outcomes.Kamil Ali-Jackson, Esq., joined us as a director in December 2021. I look forward to working with Michael and his team as they build Covis into a global leader in its areas of therapeutic focus. De Silva has served as a director on the boards of AMAG Pharmaceuticals (2012-2013) and R&D, the Canadian Pharmaceutical Association (2005-2007).ĭe Silva added: "I am delighted to join the Covis Pharma Board at a pivotal time for the company. ![]() De Silva has a BSE, Honors from Princeton University, an MS from Stanford University and an MBA with Distinction from the Wharton School at the University of Pennsylvania. De Silva started his career in pharmaceuticals at McKinsey in 1995, where he rose to Partner and a member of the leadership group of its Pharmaceuticals and Medical Products Practice. Previously, he held multiple leadership positions with Novartis AG, where he worked from 2003 to 2008. Prior to Endo, De Silva served as President of Valeant Pharmaceuticals from 2010 to 2013, and as COO of its Specialty Pharmaceuticals business from 2009 to 2013. He was President, CEO and Director of the multinational pharmaceutical company Endo International Plc from 2013 to 2016. In addition to his role as Chairman of Covis, De Silva is the Managing Partner of Asiri Advisors. This appointment, coupled with our recent partnership with Apollo, provides a solid foundation for us to continue with our global expansion via transformational acquisitions, strong organic commercial growth and product development." I look forward to working closely with him as we continue to build the business into one of the leading respiratory companies in the world and establish Covis as a leader in other attractive therapeutic areas. Michael Porter, CEO Covis Pharma, said: "Rajiv is a very accomplished strategic leader with deep experience across the pharma sector. He has a track of record of leading companies through high-growth stages as well as complex turnarounds that included organic growth, M&A, organisational restructuring and capital structure transformation. Rajiv De Silva has been chosen as Chairman of the Board of Director effective immediatelyĬovis Pharma, a global specialty pharmaceutical company, has appointed Rajiv De Silva as the Chairman of the Board of Directors.ĭe Silva is a proven business leader in the biopharmaceutical sector, with 25 years of broad international industry experience, including eight at the executive level in publicly traded healthcare companies as CEO and COO. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |